MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 03-03-2026
Agilent Technologies ROE Ratio 2011-2026 | A
Annual ROE Ratio Agilent Technologies
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 22.45 | 14.75 | 22.56 | 6.91 | 14.15 | 10.88 | 9.62 | 9.51 | 13.69 | 22.24 | 23.45 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 23.45 | 6.91 | 15.47 |
Quarterly ROE Ratio Agilent Technologies
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20.24 | 10.55 | 10.55 | 10.5 | 10.45 | 15.94 | 10.71 | 16.06 | 16.19 | 16.69 | 16.68 | 22.02 | 20.68 | 13.41 | 23.61 | 22.35 | 20.46 | 26.41 | 34.68 | 34.62 | 36.33 | 19.25 | 3.41 | 4.53 | 5.16 | 16.15 | 24.01 | 22.49 | 21.42 | 20.5 | 17.93 | 17.23 | 15.98 | 14.47 | 12.82 | 12.56 | 12.5 | 14.6 | 17.41 | 17.52 | 18.05 | 17.82 | 18.45 | 18.85 | 19.37 | 21.14 | 25.48 | 26.99 | 28.77 | 29.45 | 32.19 | 35.16 | 34.88 | 16.78 | 7.66 | 4.64 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 36.33 | 3.41 | 18.84 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M |  USA |
 |
Aspira Women's Health
AWH
|
184.36 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
9.97 | $ 25.58 | -5.68 % | $ 20 B |  Niderland |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 20.8 | -5.07 % | $ 1.11 B | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M |  Israel |
 |
Co-Diagnostics
CODX
|
-227.33 | $ 1.53 | -6.13 % | $ 2.04 M | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 24.24 | -1.86 % | $ 673 M | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 163.84 | -1.77 % | $ 8.12 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
Guardant Health
GH
|
419.18 | $ 83.41 | 0.35 % | $ 10.5 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 14.8 | -3.27 % | $ 447 M | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 1.99 | 2.9 % | $ 8.8 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 120.37 | -5.16 % | $ 19.1 B | USA |
 |
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
-121.14 | $ 2.16 | -1.22 % | $ 4.96 M | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 81.17 | -2.85 % | $ 5.48 B | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 116.17 | 13.35 % | $ 9.58 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 257.14 | -0.94 % | $ 21.4 B | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 413.59 | 0.93 % | $ 11.9 B | USA |
 |
Celcuity
CELC
|
-176.06 | $ 119.0 | -0.89 % | $ 5.56 B | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
NeoGenomics
NEO
|
-12.91 | $ 8.96 | -0.67 % | $ 1.15 B | USA |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 9.01 | -3.53 % | $ 1.95 B | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 16.54 | -1.78 % | $ 370 M | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |
 |
Myriad Genetics
MYGN
|
-99.43 | $ 4.68 | -3.31 % | $ 433 M | USA |
 |
OpGen
OPGN
|
162.49 | - | -16.95 % | $ 1.54 M | USA |
 |
Natera
NTRA
|
-77.62 | $ 194.75 | -2.71 % | $ 19.2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 189.32 | -2.94 % | $ 21 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 16.24 | -2.46 % | $ 175 M | China |
 |
Organovo Holdings
ONVO
|
-23.71 | - | -2.3 % | $ 19.4 M | USA |
 |
PerkinElmer
PKI
|
3.33 | - | -0.91 % | $ 14.7 B | USA |
 |
Personalis
PSNL
|
-40.05 | $ 5.04 | -8.36 % | $ 299 M | USA |
 |
Precipio
PRPO
|
-2.49 | $ 29.94 | -5.73 % | $ 48.1 M | USA |
 |
Exagen
XGN
|
-114.34 | $ 2.76 | 1.1 % | $ 59.5 M | USA |